APAC

Global laparoscopic ablation market projects 10.03% CAGR growth until 2028

One key trend is the emergence of next-generation ablation procedures.

Contrast media injectors market to be valued $2.3b by 2029

Rising healthcare expenditures in China and India bring forth opportunities for market growth.

What lies ahead for the BK virus infection market by 2034?

Emerging therapies are anticipated to drive its growth.

Female infertility market to value at $2.3b by 2033

It is primarily driven by an increase in women postponing pregnancy at a later age.

ParkCity Medical Centre bags Healthcare Asia Awards for cutting-edge paediatric ward

The development of technological innovations, such as PMC’s i-Kiddo ward, has transformed the healthcare landscape.

Here are factors driving the global ambulance services market

One key trend includes the rising adoption of air ambulance services in developing countries.

Anti-inflammatory therapeutics market to grow to $38.7b in 2028

This is attributed to the development of JAK inhibitors and the rising prevalence of inflammatory diseases.

Bridging gaps for a stronger care economy in Southeast Asia

A strong system necessitates addressing gender norms that equate women as caretakers.

Rural clinical and healthcare logistics market eyes 5.84% CAGR growth until 2028

The market is geared towards blockchain technology implementation within the industry.

Healthcare sector drives growth of global load monitoring systems market 

Strategic alliances are further bolstering market expansion.

Adrenocortical carcinoma market hits $22.4m in 2023

In Japan, 200 new cases of ACC were reported in 2023.

Medical transcription market to be valued $28.6b by 2028

Hospitals and clinics serve as key market consumers within the forecast period.

What lies ahead for the gender reassignment surgery market?

It is expected to grow by $369m at an 11.92% CAGR until 2028.

Diffuse large B-cell lymphoma therapeutics market to be valued $2.24b by 2028

The market is driven by advancements, such as CAR-T cell therapy and monoclonal antibodies. 

What to expect in the systemic sclerosis market by 2034

The market anticipates emerging therapies, however, economic burdens may impede its growth.